title: [Incidence and development of aortic stenosis in chronic hemodialysis. An ultrasonographic and biological study of 112 patients].
abstract: Valvular calcification in chronic haemodialysis patients has already been reported in the literature, particularly the abnormally high incidence of aortic stenosis. In this study, 112 haemodialysis patients were followed up by Doppler echocardiography for a period of 36 months. Sixteen patients developed aortic valvular calcification with aortic stenosis over an 18.7 +/- 7.5 months period. The indexed aortic valve surface area decreased from 1.24 +/- 0.9 cm2/m2 to 0.66 +/- 0.21 cm2/m2 with abnormally rapid progression. Eight patients with aortic stenosis died during the 3 year study period. These results reflect the abnormal extra-skeletal calcification of chronic haemodialysis patients. Several predisposing factors were demonstrated: age (68.5 +/- 11.1 years versus 57.1 +/- 16.3 years in patients without calcifications), male gender, a longer period of dialysis than the patients without aortic stenosis (8.1 +/- 5.3 versus 5.9 +/- 5.7 years), abnormalities of calcium and phosphate metabolism, increased of the phosphocalcic product by hyperphosphoraemia and not by hypercalcaemia, hypoparathyroidism in 62% and hyperparathyroidism in 38% an increase in vitamin D 3 (19.7 +/- 14 ng/ml versus 9.6 +/- 6.3 ng/ml) biological signs of adynamic osteodystrophy. Calcific aortic stenosis is a commonly observed valvular lesion in haemodialysis patients: its progression may be very rapid, associated with a poor prognosis. Old age, male gender, duration of haemodialysis, hyperphosphataemia associated with hypoparathyroidism and raised Vitamin D3 are predisposing factors.
authors.affiliation: Service de néphrologie et hémodialyse, clinique de l'Orangerie, Aubervilliers.
authors.forename: M C
authors.initials: MC
authors.lastname: Malergue
authors.forename: P
authors.initials: P
authors.lastname: Urena
authors.forename: P
authors.initials: P
authors.lastname: Prieur
authors.forename: C
authors.initials: C
authors.lastname: Guédon-Rapoud
authors.forename: M
authors.initials: M
authors.lastname: Pétrover
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001024:Aortic Valve Stenosis / Q000097:blood / Q000000981:diagnostic imaging / Q000209:etiology; D002114:Calcinosis / Q000097:blood / Q000000981:diagnostic imaging / Q000209:etiology; D002128:Calcium Metabolism Disorders / Q000150:complications; D002762:Cholecalciferol / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010760:Phosphorus Metabolism Disorders / Q000150:complications; D011379:Prognosis; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D014463:Ultrasonography
chemical_list: D002762:Cholecalciferol
vernacular_title: Incidence et évolutivité des rétrécissements aortiques chez l'hémodialysé chronique. Une étude échographique et biologique sur une population de 112 patients.